Cerebras Systems Inc.
Cerebras Systems designs and develops processors for artificial intelligence applications. Its products support AI model training and inference, the process of using trained models to generate results. The company operates in the United States, Europe and Asia and is based in Sunnyvale, California.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Cerebras Systems (CBRS) was chosen by Bilt to power its AI platforms, serving 8M+ members and 50K merchants. They plan to expand Cerebras' inference use; specifics on availability and performance are pending. No financial details were disclosed.
Wedbush reduced its price target for Cerebras Systems (CBRS) to $190 from $290 ahead of earnings, citing data center concerns. Shares declined slightly in premarket trading.
Rosenblatt Securities cut its price target for Cerebras Systems (CBRS) to $170 from a prior target, maintaining a Buy rating. The firm reduced its valuation multiple due to broader AI sector pressure and competitive dynamics. Cerebras shares have fallen 65% since Q2 2026 earnings, trading at $89.68. Rosenblatt noted Cerebras' multiyear OpenAI contract and strong inference technology but cited peer valuation compression. Other analysts have mixed price targets, ranging from $175 to $300.
Over the past 7 days, AlphAI's AI scored 9 news stories mentioning CBRS (Cerebras Systems Inc.). Coverage has skewed bearish: 3 bullish, 1 neutral, and 5 bearish.
Recent CBRS coverage spans financial news, market movers and earnings.
In the last 30 days, CBRS insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($6.9M). The most active reporter was Lie Sean, Chief Technology Officer, with 3 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
The contract adds a notable commercial customer but lacks disclosed financial terms, limiting immediate price impact.
Analyst target reduction suggests weaker near‑term outlook.
Analyst target cut suggests near-term downside pressure on CBRS.
Guidance above prior estimates could lift the stock.
Shares likely to stay under pressure as market sentiment remains negative.
AlphAI scores every news story that mentions CBRS with an AI model for sentiment and relevance, and aggregates insider trades from Cerebras Systems Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cerebras Systems (CBRS) was chosen by Bilt to power its AI platforms, serving 8M+ members and 50K merchants. They plan to expand Cerebras' inference use; specifics on availability and performance are pending. No financial details were disclosed.
Wedbush reduced its price target for Cerebras Systems (CBRS) to $190 from $290 ahead of earnings, citing data center concerns. Shares declined slightly in premarket trading.
Rosenblatt Securities cut its price target for Cerebras Systems (CBRS) to $170 from a prior target, maintaining a Buy rating. The firm reduced its valuation multiple due to broader AI sector pressure and competitive dynamics. Cerebras shares have fallen 65% since Q2 2026 earnings, trading at $89.68. Rosenblatt noted Cerebras' multiyear OpenAI contract and strong inference technology but cited peer valuation compression. Other analysts have mixed price targets, ranging from $175 to $300.
CoreWeave, Cisco, Applied Materials, and others report earnings this week. CoreWeave guided to $3.45-3.6B Q3 revenue and $11.5-13.5B capex. Cisco expects $18.0-18.2B revenue. October CPI data is due Tuesday, with economists expecting 0.3% rise. Fed hike odds at 80% for December meeting. Rocket Lab, AST SpaceMobile, and Plug Power also report Monday.
Cerebras Systems (CBRS) shares fell 18% in a week amid a broader AI sector sell-off, despite no company-specific news. Analysts expect revenue to triple by 2027, with the stock's forward sales multiple declining from its June peak. CoreWeave (CRWV) also dropped 16%, and Oracle (ORCL) fell 11% on AI-related concerns. The third-quarter report and IPO lockup expiration are upcoming.
Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.
Oracle will offer Google's TPU chips in its data centers starting 2027, along with other AI accelerators. The move makes OCI the first hyperscale cloud outside Google to provide TPUs. Pricing and exact availability dates for most chips remain undisclosed. Oracle also announced software integrations with OpenAI models and other AI services. Cerebras (CBRS) and SambaNova are among the other chip vendors involved.
Cerebras Systems (CBRS) stock fell 6% after Intel (INTC) reported strong earnings but issued weak Q4 guidance, raising concerns about AI sector health. Both companies are AI-focused, but Intel's issues stem from PC sales, not AI. Intel's CFO noted strong AI demand, suggesting Cerebras may not be impacted.
ARK ETFs bought 45,729 shares of Cerebras Systems (CBRS) for $5.15M and added to Beam Therapeutics (BEAM) and Joby Aviation (JOBY). They sold 7,625 shares of Tempus AI (TEM) for $584,151, along with smaller reductions in 10X Genomics (TXG), Rubrik (RBRK), CrowdStrike (CRWD), and Cloudflare (NET).
Lie Sean (Chief Technology Officer) sold 60,000 shares of Cerebras Systems Inc. (CBRS) at an average of $115.79 ($113.92–$116.82, $6.95M total) across 3 trades on 2026-10-27 under a Rule 10b5-1 trading plan.
